Humacyte, Inc. - HUMA

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$59.84M

QoQ value delta ($000)

+$22.49M (+60.2%)

Implied price effect (QoQ)

+28.38%

Total shares

76,828,789

QoQ shares delta

+15,260,093 (+24.79%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 169 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
ANTIPODES PARTNERS Ltd	7,884	10,103,647	0.14%
VANGUARD CAPITAL MANAGEMENT LLC	7,883	10,107,679	0.0%
Alyeska Investment Group, L.P.	4,700	6,022,925	0.01%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP	3,902	5,000,000	0.05%
BlackRock, Inc.	3,777	4,839,929	0.0%
GREAT POINT PARTNERS LLC	2,926	3,750,000	0.55%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	2,254	2,890,043	0.0%
UBS Group AG	2,217	2,843,493	0.0%
AQR CAPITAL MANAGEMENT LLC	2,026	2,597,134	0.0%
GEODE CAPITAL MANAGEMENT, LLC	1,706	2,185,225	0.0%
MILLENNIUM MANAGEMENT LLC	1,489	1,909,049	0.0%
CITADEL ADVISORS LLC	1,458	1,869,076	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1,056	1,353,515	0.0%
VANGUARD FIDUCIARY TRUST CO	921	1,181,276	0.0%
HRT FINANCIAL LP	850	1,089,508	0.0%
LPL Financial LLC	800	1,025,535	0.0%
GSA CAPITAL PARTNERS LLP	785	1,005,709	0.05%
Private Advisor Group, LLC	753	965,091	0.0%
STATE STREET CORP	657	842,537	0.0%
HBK INVESTMENTS L P	616	790,000	0.01%
WEALTH EFFECTS LLC	541	693,920	0.15%
SIMPLEX TRADING, LLC	527	676,200	0.0%
Lion Point Capital, LP	507	650,000	2.43%
LuminArx Capital Management LP	507	650,000	0.23%
GOLDMAN SACHS GROUP INC	457	586,524	0.0%